Spinocerebellar Ataxia Type 16
Neurology·MeSH: Lambert-Eaton Myasthenic Syndrome
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Spinocerebellar Ataxia Type 16?
There are 1 clinical trial targeting Spinocerebellar Ataxia Type 16 tracked by BioSniper.
What is the prevalence of Spinocerebellar Ataxia Type 16?
The estimated prevalence of Spinocerebellar Ataxia Type 16 is approximately 5.0 per 100,000 population.
Deep-dive into Spinocerebellar Ataxia Type 16
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis